Rich *********
******* **** *********, ***** ** ****** a ******* *** ****.
***** ** ******** **** ** ******* and *** *******, ***** ** * lot *** * ******* **** ** trending**** **** ******-***** ****** *****.
******, ****** **** ********* ** ***** growth ***** (**********) ** ** *** 16% - **% *****, ** **** this **** ** *******. *** ***, with *** ********** ** **** ***** and ****** ********** *********** **** *****, at ***** ** *** ***** ****, Axis **** ** ******* ********.
Canon ******* ** ** *******
***** *** ***** **** * *********** player ** ** *******, ** *** measure. ****** **** **** *** ** IP ****** **** *** *****, ** has ****** **** ************* *******, **** a ****** ***** *** ** ***** differentiators. *** ********* **** ** ***** ** *******.
******** ** ***, ***** ****'* ********* broad ****** ********, **** ***** ***** a ******* ****** ** *** ************ industry ***.
Canon, *********, *** ****
*******, *** ******* ********* ****** ** Canon ****** **** *********, *** ** the ******* *** *********, *** ****, one ** *** ******* ** ****** developers.
** ****, **** ***** ******** *********, the ******* ******* *** ******* ***** was ***** ** ******* *** ** cameras **** *********'* *** ********. ************, Milestone ******* ** ** ****** ************ agnostic. ******, ********* **** ******* ******* pains ** ****** ******** **** ***** would **** ** ********* ** **** and **** ***** ***** ** * Chinese **** ******* *** ***.
***, ** ******* **** *** ********* will ** ********, **** ******** **** ever. ** *** **** ***** *** early *****, **** *** *********, **** ~50 ***** *****, ****** ******** *********, helped **** ***** ******* **** *** significant ****** **** **** *** *****.
The ***** **** / ********* ********
** ***** ****** ***** **** ***** end-to-end ********* ** **** *** *********, with *****-******* *** ********* *** ****** the *******. ** ***** **** *** do ****, ***** ******, **** *** fools.
**** ******* **** **** ****** * stronger *** *** *** ** ********** its ***** ***, *******, ********* ** a **** ******* **** **** **** previously *******.
********, ** ***** ***********'* *********** ** * *** **** week, ******* * '********' ** ******** to ********* **** ***-**** ******* *******. Chinese ************* *** ******* ** *** VMS / ******** ****, ** ********* a ****-*** *** ** * *** tactic ** *************** ******* ******* **** are *** ***** ****.
Consolidation *** ******** ********
*** *****, ******* **** ********** ************* was ***** ** ******. **** ****, they *** *****. *** ******** ************ ******** ***** **** *** past ** ******.
*** *** ** *** ** ****** growth *** ** * *** ****** for ****. *** **** ****** ** transitioning **** ** ****** ** ** is *** ** *** **** *** and *** *** ***** ******** **, **** *** ***** *** *****, is *** *** ****** *** ***** brands.
****** ****, ** ************ *** **** able ** ******** * ***** *** growth ****, **** *** ********, *** is ****** * ******* *** ** analytics, ************ ********** ***** ****** $*** ******* ** patents (*.*.,*****).
Can ***** *******?
***** *** * *** *** ***** of **, ********* **** *** ******** out **** ** ** **** **** Axis *** *********. **** ********* **** championed *** ******* ** *** **** platform *** ******* **** ********. *** transition ** ********** ** * ******** conglomerate ** ***** ** ** ***********.
Who **** / *** *****?
** **** *****, **** (***** ********* at *****) *** ****. ********* *** deal ***** *** ******* ****** ********** in *** *** ******. **** **** already ******, **** *** *** **** the ********* *** *** ****.
********* ** *** ***** ****, **** the *******, *** ********* *** ******** lose ****, ** **** **** ** deal **** *** *** ** ***** an *********** ******** ******.
***************, ****' *** ****** **** ********* and ********, ***** ** **** **** the ********** ********, ********* *** ******* that ***** ************ ******.
****** ****, ** **** ****** ** what ***** ****, *** ** ***** suspect **** **** *** *********'* **** innovating *** ****** ****** ****, **** if ***** *** ******** **** ******* from *** ***.
*** ***********, *** *** **** ***** *********** surveillance ************. *** *** ** ***** they *** *** #* ****** *** consolidation ****, ***** ***** **** **** rich *******, ** ***** *****. [******: Genetec*** ******** * ********* ** *** deal.]
What ** *** *****?

